West Pharmaceutical Services Inc. (WST) Shares Bought by Swiss National Bank
Swiss National Bank grew its holdings in West Pharmaceutical Services Inc. (NYSE:WST) by 2.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 126,000 shares of the medical instruments supplier’s stock after purchasing an additional 3,000 shares during the quarter. Swiss National Bank owned about 0.17% of West Pharmaceutical Services worth $12,432,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in WST. California Public Employees Retirement System raised its stake in shares of West Pharmaceutical Services by 3.0% in the fourth quarter. California Public Employees Retirement System now owns 162,472 shares of the medical instruments supplier’s stock valued at $16,031,000 after acquiring an additional 4,713 shares during the last quarter. M&T Bank Corp raised its position in West Pharmaceutical Services by 28.9% in the 4th quarter. M&T Bank Corp now owns 80,133 shares of the medical instruments supplier’s stock worth $7,906,000 after purchasing an additional 17,957 shares during the last quarter. ING Groep NV bought a new position in West Pharmaceutical Services in the 4th quarter worth approximately $249,000. Alps Advisors Inc. bought a new position in West Pharmaceutical Services in the 4th quarter worth approximately $206,000. Finally, US Bancorp DE raised its position in West Pharmaceutical Services by 25.9% in the 4th quarter. US Bancorp DE now owns 8,019 shares of the medical instruments supplier’s stock worth $792,000 after purchasing an additional 1,651 shares during the last quarter. 94.37% of the stock is currently owned by institutional investors.
West Pharmaceutical Services Inc. (WST) opened at $91.31 on Friday. The firm has a market cap of $6,811.94, a price-to-earnings ratio of 45.88, a P/E/G ratio of 2.34 and a beta of 1.15. The company has a debt-to-equity ratio of 0.15, a current ratio of 2.66 and a quick ratio of 1.89. West Pharmaceutical Services Inc. has a one year low of $77.97 and a one year high of $103.36.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 2nd. Shareholders of record on Wednesday, April 18th will be given a dividend of $0.14 per share. The ex-dividend date is Tuesday, April 17th. This represents a $0.56 annualized dividend and a yield of 0.61%. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 28.14%.
West Pharmaceutical Services announced that its Board of Directors has initiated a share buyback plan on Thursday, February 15th that permits the company to repurchase 800,000 outstanding shares. This repurchase authorization permits the medical instruments supplier to purchase shares of its stock through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.
WST has been the subject of several research analyst reports. Zacks Investment Research cut shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Saturday, January 6th. Goldman Sachs Group started coverage on shares of West Pharmaceutical Services in a report on Wednesday, January 24th. They set a “neutral” rating and a $110.00 target price for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the company’s stock. West Pharmaceutical Services has a consensus rating of “Hold” and an average price target of $108.17.
ILLEGAL ACTIVITY WARNING: “West Pharmaceutical Services Inc. (WST) Shares Bought by Swiss National Bank” was originally posted by Marea Informative and is the sole property of of Marea Informative. If you are reading this news story on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark laws. The original version of this news story can be viewed at https://www.mareainformativa.com/2018/03/16/swiss-national-bank-boosts-position-in-west-pharmaceutical-services-inc-wst-updated-updated-updated.html.
West Pharmaceutical Services Company Profile
West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.